Natural health product · NPN 80079599
Capros
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed August 22, 2017; licence last revised July 15, 2024.
- Natural Product Number (NPN)
- 80079599
- Licence holder
- Kerry Inc.
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- August 22, 2017
- Licence last revised
- July 15, 2024
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Phyllanthus emblica | 250 milligrams | Phyllanthus emblica - fruit; 60 % Tannins |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Capros helps to reduce C-reactive protein levels, a clinical marker of inflammation. Capros promotes the production of glutathione, an important antioxidant in the body, to fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Capros helps decrease low density lipoprotein, cholesterol and inhibit collagen induced platelet aggregation which contribute to the maintenance of normal cardiovascular function/health. Capros helps protect against oxidative stress by serving as a natural source of antioxidants. Capros helps protect cells against damage from oxidative stress. Capros is a source of antioxidants that helps reduce the oxidative damage caused by free radicals.
Non-medicinal ingredients
Hypromellose